Patents by Inventor John F. Price

John F. Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240077159
    Abstract: A one-hand engageable vacuum tool connection assembly for connection to a commercial vehicle vacuum system that includes: a vacuum tool connection assembly hose having a first end and a second end; an upper assembly and a lower assembly having a tool connector where the tool connector engages a second end of the lower assembly swivel cuff and is typically adapted to receive one or a plurality of different types of vacuum tools. The vacuum tool engagement assembly is typically free of any flapper valve, metal or spring biased elements.
    Type: Application
    Filed: January 5, 2022
    Publication date: March 7, 2024
    Inventors: Justin Taylor Heaps, Steve W. Lieneman, Jared Leroy Meacham, Clay D. Price, Eldered Tom Tucker, Jr., John F. Tucker
  • Patent number: 11761947
    Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: September 19, 2023
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Paul Galley, Alan Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
  • Publication number: 20200049691
    Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.
    Type: Application
    Filed: October 22, 2019
    Publication date: February 13, 2020
    Inventors: Paul GALLEY, Alan GREENBURG, Marshall M. PARKER, John F. PRICE, Robin S. WAGNER, Richard W. WILSON
  • Patent number: 10458973
    Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: October 29, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
  • Patent number: 10368745
    Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: August 6, 2019
    Assignee: ROCHE DIABETES CARE INC
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
  • Patent number: 10251583
    Abstract: A device and method for delivering insulin to a patient is disclosed. The method includes receiving an amount of insulin to deliver to a patient and beginning delivery of the insulin to the patient. The method further includes monitoring the delivery of the insulin to determine whether the insulin pump is able to deliver the entire amount of insulin and maintaining a timer until the insulin pump recommences the delivery of the insulin. The method includes comparing an amount of time indicated by the timer to a threshold. The method further includes generating a first insulin delivery record indicating that a first amount of insulin was delivered when the amount of time indicated by the timer is less than the threshold and a second insulin record indicating that a second amount of insulin was delivered when the amount of time indicated by the timer is greater than the threshold.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 9, 2019
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Nicole Bernini, Paul J. Galley, Stefan Lindegger, John F. Price, Reto Sigrist, Robin S. Wagner, Richard W. Wilson
  • Patent number: 9918635
    Abstract: Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: March 20, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
  • Patent number: 9786024
    Abstract: According to some aspects of the present disclosure a method for presenting a GUI for modifying medical data on a handheld medical device is disclosed. The method includes determining a correction bolus amount and a meal bolus amount for the patient. The method also includes presenting the GUI on a display of the medical device and presenting the correction bolus amount, the meal bolus amount and a total bolus amount in the GUI. The method also includes presenting a correction bolus amount modification field and a meal bolus amount field in the GUI. The correction bolus amount modification field and the meal bolus amount modification field allow the patient to provide input to modify the correction bolus amount and meal bolus amount, respectively. The method further includes receiving the input and generating an advice history record based on the input.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: October 10, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
  • Patent number: 9549324
    Abstract: A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: January 17, 2017
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Daniel Birtwhistle, Thomas D. Gurley, Mark Nierzwick, Ulrich Porsch, John F. Price, Blaine E. Ramey, Raymond Strickland
  • Patent number: 9213802
    Abstract: A method of improving updatability of entry, adherence, and exit criteria stored in memory of a handheld diabetes management device, the method includes: providing the handheld diabetes management device with a blood glucose (bG) measurement engine that measures a bG level in a sample of blood of a user and that generates sample data indicative of the bG level; providing the handheld diabetes management device with the memory and a touchscreen display; providing the handheld diabetes management device with a processor module that is in communication with the bG measurement engine, the touchscreen display, and the memory; storing firmware that is executable by the processor module for performing operations to carry out a structured bG test in a non-modifiable portion of the memory; and storing the entry, adherence, and exit criteria in a modifiable portion of the memory.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: December 15, 2015
    Assignee: Roche Diabetes Care, Inc.
    Inventors: John F. Price, Paul J. Galley
  • Patent number: 9087149
    Abstract: A method for conducting a Testing In Pairs (TIPs) blood glucose (bG) test using a handheld diabetes management device carried by a user. A processing subsystem of the device implements a software module for managing the TIPs test. The software module generates a plurality of predetermined acceptance time windows corresponding to different user defined events. The processing subsystem can identify specific ones of a plurality of bG test values read by the device that are obtained during the predetermined bG acceptance time windows, and which are identified as being related pairs of accepted bG test values that correspond to specific ones of the user defined events. The related pairs of accepted bG test values can then be stored in a database.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: July 21, 2015
    Assignee: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Paul J. Galley, John F. Price, Richard W. Wilson, Lisa McCool
  • Publication number: 20140230021
    Abstract: A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
    Type: Application
    Filed: January 24, 2014
    Publication date: August 14, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Daniel Birtwhistle, Thomas D. Gurley, Mark Nierzwick, Ulrich Porsch, John F. Price, Blaine E. Ramey, Raymond Strickland
  • Patent number: 8707392
    Abstract: A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: April 22, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Daniel Birtwhistle, Ulrich Porsch, John F. Price, Raymond Strickland
  • Publication number: 20140058749
    Abstract: According to some aspects of the present disclosure a method for presenting a GUI for modifying medical data on a handheld medical device is disclosed. The method includes determining a correction bolus amount and a meal bolus amount for the patient. The method also includes presenting the GUI on a display of the medical device and presenting the correction bolus amount, the meal bolus amount and a total bolus amount in the GUI. The method also includes presenting a correction bolus amount modification field and a meal bolus amount field in the GUI. The correction bolus amount modification field and the meal bolus amount modification field allow the patient to provide input to modify the correction bolus amount and meal bolus amount, respectively. The method further includes receiving the input and generating an advice history record based on the input.
    Type: Application
    Filed: August 24, 2012
    Publication date: February 27, 2014
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
  • Publication number: 20140058237
    Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.
    Type: Application
    Filed: August 24, 2012
    Publication date: February 27, 2014
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
  • Publication number: 20140025400
    Abstract: A device, method, and graphical user interface for displaying diabetes related information sets aligned by the occurrence of a particular event are disclosed. After receiving a request for an event-aligned display of diabetes related information based on an event, a search for a plurality of tagged occurrences of the event and retrieval of an information set for each of the plurality of tagged occurrences is provided. Each information set may include diabetes related information chronologically related to the tagged occurrence. The retrieved information sets is displayed on a display, wherein the retrieved information sets are shown on the display aligned by their tagged occurrences such that all diabetes related information is positioned relative the event based on its chronological relationship with the event.
    Type: Application
    Filed: October 2, 2013
    Publication date: January 23, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Paul J. Galley, John F. Price
  • Patent number: 8615366
    Abstract: A method for monitoring blood glucose (bG) levels of a diabetic user. The method may be implemented on a non-transitory computer readable medium adapted to run on a processing subsystem, the processing subsystem forming a portion of a handheld diabetes management device for monitoring the bG levels of a diabetic user and determining a correction bolus to be provided to the user. The method may comprise using a memory to store information in a plurality of different time blocks. The information may include a plurality of differing user defined health events that each include a predetermined associated percentage value set by the user by which a correction bolus calculation will be modified to account for one of an increase or a decrease in insulin associated with each one of the defined health events. The processing subsystem may be used to communicate with the memory and to obtain the information and to calculate therefrom the correction bolus.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: December 24, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Paul J. Galley, Richard W. Wilson, John F. Price, Alan M. Greenburg, Marshall Parker
  • Patent number: 8579815
    Abstract: A device, method, and graphical user interface for displaying diabetes related information sets aligned by the occurrence of a particular event are disclosed. After receiving a request for an event-aligned display of diabetes related information based on an event, a search for a plurality of tagged occurrences of the event and retrieval of an information set for each of the plurality of tagged occurrences is provided. Each information set may include diabetes related information chronologically related to the tagged occurrence. The retrieved information sets is displayed on a display, wherein the retrieved information sets are shown on the display aligned by their tagged occurrences such that all diabetes related information is positioned relative the event based on its chronological relationship with the event.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: November 12, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Paul J. Galley, John F. Price
  • Patent number: 8515775
    Abstract: A method is disclosed for managing a three day profile blood glucose (bG) measurements that are provided by a user using a handheld diabetes management device. The method may involve configuring a database carried by the device to store a plurality of bG test values input by a user for each day of a three day test period. The bG test values are required to be provided by the user in accordance with a predetermined plurality of differing acceptance time windows during each day of the three day test period. If two or more windows are open concurrently when a given bG test value is obtained, the system allows the user to select the appropriate time window that the given bG test value should be associated with.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: August 20, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Paul J. Galley, John F. Price, Richard W. Wilson, Lisa McCool
  • Publication number: 20130212381
    Abstract: Methods and systems for authorizing access to a medical device are disclosed. The methods and systems use authorization certificates to allow and prevent access to one or more operations of the medical device. The methods and systems also allow the tracking of changes made to the medical device by an authorized user.
    Type: Application
    Filed: February 15, 2012
    Publication date: August 15, 2013
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Steven A. Bousamra, Douglas M. Charboneau, Daniel J. DiSalvo, Alan M. Greenburg, Ulrich Porsch, John F. Price, Raymond A. Strickland, William T. Tucek, Stefan Weinert